First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $272.91 and last traded at $272.02, with a volume of 49511 shares. The stock had previously closed at $268.96.
First Trust NYSE Arca Biotechnology Index Fund Price Performance
The firm’s 50 day moving average is $249.58 and its two-hundred day moving average is $222.28. The firm has a market capitalization of $3.00 billion, a P/E ratio of 21.72 and a beta of 0.66.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently modified their holdings of the company. High Point Wealth Management LLC acquired a new position in shares of First Trust NYSE Arca Biotechnology Index Fund during the 4th quarter worth about $26,000. Russell Investments Group Ltd. lifted its stake in First Trust NYSE Arca Biotechnology Index Fund by 7,900.0% in the 3rd quarter. Russell Investments Group Ltd. now owns 160 shares of the company’s stock valued at $29,000 after purchasing an additional 158 shares during the last quarter. AG Campbell Advisory LLC acquired a new stake in First Trust NYSE Arca Biotechnology Index Fund in the 4th quarter valued at about $31,000. Cassaday & Co Wealth Management LLC bought a new position in First Trust NYSE Arca Biotechnology Index Fund during the first quarter worth about $34,000. Finally, Continuum Advisory LLC bought a new stake in First Trust NYSE Arca Biotechnology Index Fund in the second quarter valued at approximately $35,000.
About First Trust NYSE Arca Biotechnology Index Fund
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.
Read More
- Five stocks we like better than First Trust NYSE Arca Biotechnology Index Fund
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Receive News & Ratings for First Trust NYSE Arca Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology Index Fund and related companies with MarketBeat.com's FREE daily email newsletter.
